title: Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis.
abstract: Recent electrophysiological studies on peripheral autonomic dysfunction in leprosy patients show a high prevalence of autonomic dysfunction as measured by abnormal vasomotor reflexes (VMR) and absent sympathetic skin response (SSR). Nothing is known about the reversibility of these autonomic parameters with treatment. Since there is evidence that small fiber function may be the most reversible component in neuropathies, we measured the effect of steroid treatment on autonomic parameters together with motor and sensory functions in leprosy patients with acute neuritis. Control subjects were investigated for repeatability testing of autonomic function. Due to a relatively high variability on repeat VMR testing in the controls, we defined a change in VMR testing as a change of > 30%. With this definition, the VMR of 14.8% of the patients improved, 75% remained unchanged, and 10.2% worsened. Absent SSR became positive in 16.6% and remained unchanged in 83.4%. Improvement in sensory motor functions was seen in 21.2% and 1.3% of the patients, respectively.
authors.affiliation: D.T.M.&H., Medical Services International, Mongkok, Hong Kong.
authors.forename: A
authors.initials: A
authors.lastname: Wilder-Smith
authors.forename: E
authors.initials: E
authors.lastname: Wilder-Smith
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D017776:Autonomic Pathways / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D002648:Child; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000294:innervation / Q000473:pathology; D009443:Neuritis / Q000188:drug therapy / Q000382:microbiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000382:microbiology; D010865:Pilot Projects; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012867:Skin / Q000294:innervation / Q000473:pathology; D014666:Vasomotor System / Q000473:pathology
chemical_list: D005938:Glucocorticoids; D011239:Prednisolone